Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20784 | 385 | 31.5 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1472 | 7159 | SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS//LUPUS NEPHRITIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CRA DIP | Address | 2 | 67% | 1% | 2 |
2 | SECC INMUNOGENET | Address | 1 | 100% | 1% | 2 |
3 | SERV ATENDIMENTO ESPECIALIZADO SMS BELFORD ROXO | Address | 1 | 100% | 1% | 2 |
4 | UNITE INFECTIOL | Address | 1 | 40% | 1% | 2 |
5 | AUTOSPLENECTOMY | Author keyword | 1 | 33% | 1% | 2 |
6 | INFECTOL MICROBIOL | Address | 1 | 33% | 1% | 2 |
7 | SECT RHEUMATOL CLIN IMMUNOL OSTEOPOROSIS | Address | 1 | 23% | 1% | 3 |
8 | ABDOMINAL VASCULITIS | Author keyword | 1 | 50% | 0% | 1 |
9 | DISSEMINATED NOCARDIA | Author keyword | 1 | 50% | 0% | 1 |
10 | GONOCOCCEMIA | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RHEUMATOLOGIC DISEASES | 9 | 83% | 1% | 5 |
2 | SPLENIC ATROPHY | 2 | 36% | 1% | 5 |
3 | FUNCTIONAL ASPLENIA | 1 | 24% | 1% | 5 |
4 | C5 DERIVED CHEMOTACTIC ACTIVITY | 1 | 50% | 0% | 1 |
5 | NONTYPHOID SALMONELLOSIS | 1 | 50% | 0% | 1 |
6 | PATIENTS RECEIVING CORTICOSTEROIDS | 1 | 50% | 0% | 1 |
7 | SINGLE COHORT | 1 | 29% | 1% | 2 |
8 | SALMONELLA SEPTIC ARTHRITIS | 1 | 25% | 1% | 2 |
9 | HYPOSPLENISM | 0 | 11% | 1% | 4 |
10 | 513 DANISH PATIENTS | 0 | 14% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Infections in the lupus patient: perspectives on prevention | 2011 | 15 | 62 | 40% |
Infectious complications in SLE after immunosuppressive therapies | 2003 | 92 | 73 | 45% |
Systemic lupus erythematosus and tuberculosis: A review of complex interactions of complicated diseases | 2010 | 7 | 31 | 68% |
Infections in systemic lupus erythematosus | 2010 | 19 | 62 | 32% |
Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence | 2007 | 18 | 32 | 47% |
Interplay of Infections, Autoimmunity, and Immunosuppression in Systemic Lupus Erythematosus | 2014 | 4 | 227 | 13% |
Systemic lupus erythematosus and infections: Clinical importance of conventional and upcoming biomarkers | 2012 | 25 | 52 | 12% |
Septic arthritis in patients with systemic lupus erythematosus: Salmonella and nonsalmonella infections compared | 2006 | 16 | 29 | 48% |
Rheumatic patients in the intensive care unit | 2012 | 2 | 23 | 48% |
Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature | 2005 | 20 | 20 | 45% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CRA DIP | 2 | 67% | 0.5% | 2 |
2 | SECC INMUNOGENET | 1 | 100% | 0.5% | 2 |
3 | SERV ATENDIMENTO ESPECIALIZADO SMS BELFORD ROXO | 1 | 100% | 0.5% | 2 |
4 | UNITE INFECTIOL | 1 | 40% | 0.5% | 2 |
5 | INFECTOL MICROBIOL | 1 | 33% | 0.5% | 2 |
6 | SECT RHEUMATOL CLIN IMMUNOL OSTEOPOROSIS | 1 | 23% | 0.8% | 3 |
7 | JPN | 1 | 50% | 0.3% | 1 |
8 | MYCOBACTERIAL DIS INT HLTH | 1 | 50% | 0.3% | 1 |
9 | SANTA CLARA CTY TB CLIN | 1 | 50% | 0.3% | 1 |
10 | SERV MALAD INFECT TROP INFECT NECKER PASTEU | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000233173 | HYPOSPLENISM//CAVITATING MESENTERIC LYMPH NODE SYNDROME//LYMPH NODE CAVITATION |
2 | 0.0000194666 | FUNDACIO RECERCA MUTUA TERRASSA//INCUMBENT LAURA WARZ KIP CHAIR AUTOIMMUNE//AUTOIMMUNE INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS |
3 | 0.0000182449 | LUPUS NEPHRITIS//SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS |
4 | 0.0000179263 | SALMONELLA MENINGITIS//NONTYPHOIDAL SALMONELLA//SALMONELLA BACTEREMIA |
5 | 0.0000153429 | SLAM ASSOCIATED PROTEIN SAP//ANTI CMV ANTIBODIES//VARICELLA ARTHRITIS |
6 | 0.0000153228 | PYOGENIC SACROILIITIS//SEPTIC SACROILIITIS//COMBATIVENESS |
7 | 0.0000119727 | SHRINKING LUNG SYNDROME//IDIOPATHIC PULMONARY HEMOSIDEROSIS//PULMONARY HEMOSIDEROSIS |
8 | 0.0000071687 | SEPTIC ARTHRITIS//BACTERIAL ARTHRITIS//INFECTIOUS ARTHRITIS |
9 | 0.0000063407 | PASS//COMMUNITY ACQUIRED INFECTIOUS DISEASES//PPD TUBERCULIN |
10 | 0.0000063323 | NITROXOLINE//NEWBORNS AT RISK//MYCOPHOBIA |